a Any quality TRAEs
a Any quality TRAEs. 0.001) than nivolumab alone. Weighed against ipilimumab by itself, the mixed immunotherapy group acquired better CR (RR: 4.89, 0.001), PR (RR: 2.75, 0.001), and ORR (RR: 3.31, 0.001). Finally, Rabbit Polyclonal to TISB N1I3 demonstrated better PR (RR: 1.35, = 0.006) and ORR (RR: 1.21, = 0.03) than N3We1. The occurrence…